What is Triumph Therapeutics?
Triumph Therapeutics is a specialized pediatric therapy clinic based in Washington DC, offering a comprehensive suite of services including physical therapy, speech therapy, and occupational therapy. The clinic is dedicated to providing personalized, play-based therapeutic interventions designed to foster development in children across various age groups. By focusing on improving communication, enhancing motor skills, and supporting daily functioning, Triumph Therapeutics aims to empower children to thrive in a nurturing environment. The clinic's approach emphasizes individualized treatment plans, developed by a dedicated team led by founder Omololu Majekodunmi, to meet the unique needs of each child. Serving families in Washington DC, Bethesda, and Chevy Chase, the clinic extends its reach through both in-clinic and in-home therapy options, underscoring its commitment to accessibility and family-centered care.
How much funding has Triumph Therapeutics raised?
Triumph Therapeutics has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Triumph Therapeutics
PPP
Public-Private Partnership
What's next for Triumph Therapeutics?
With the recent influx of substantial expansion capital, Triumph Therapeutics is poised for a strategic scaling phase, likely focusing on expanding its service offerings, increasing its geographic reach within the Washington DC metropolitan area, and potentially enhancing its technological infrastructure to support its personalized therapy models. The significant Series B/C stage funding suggests an intent to solidify its market position as a leading provider of pediatric therapeutic services, possibly through team expansion, new facility development, or strategic partnerships. This investment will be critical in furthering its mission to help children achieve their developmental milestones.
See full Triumph Therapeutics company page
